XLS Download (not available)
Print this page Compare to last year's report

Specialty Chemicals – Overview

  • Revenue increased by 4 percent, mainly due to the Boxing Oleochemicals acquisition
  • EBITDA decreased 2 percent to €235 million against a strong Q1 2011, driven mainly by Functional Chemicals
  • EBITDA margin remained strong at 16.8 percent (2011: 17.8 percent)

Revenue increased 4 percent, mainly due to the Boxing Oleochemicals acquisition and a positive price/mix effect. The volume dip in Q4 2011 of 4 percent appears to have been due to temporary customer destocking as we have seen some recovery, but the overall trend is still slightly negative. EBITDA came in 2 percent lower, reflecting different trading conditions across businesses. Results in Functional Chemicals declined, impacted by a supply/demand imbalance in Ethylene Amines and in Chemicals Pakistan, the domestic market conditions remain difficult. Pulp and Performance Chemicals and Surface Chemistry saw earnings improve relative to Q1 last year, while Industrial Chemicals also performed well.

Revenue development Q1 2012

Specialty Chemicals – Revenue development Q1 2012 (bar chart)
Specialty Chemicals – Brands (logos)
Copyright © 2012 Akzo Nobel N.V.